Steigerwald, Gordon & Koch Inc. Abb Vie Inc. Transaction History

Steigerwald, Gordon & Koch Inc.

$932 Million
Q2 2025

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 3,283 shares of ABBV stock, worth $621,504. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,283

Previous 3,361 2.32%

Holding current value

$621,504

Previous $704,000 13.49%

% of portfolio

0.07%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	SELL	$170.16 - $206.27 $13,272 - $16,089	-78 Reduced 2.32%	3,283 $609,000
Q1 2025 Apr 10, 2025	BUY	$169.2 - $216.66 $20,811 - $26,649	123 Added 3.8%	3,361 $704,000
Q4 2024 Jan 16, 2025	SELL	$164.99 - $203.87 $17,653 - $21,814	-107 Reduced 3.2%	3,238 $575,000
Q3 2024 Oct 09, 2024	BUY	$163.84 - $199.33 $16,547 - $20,132	101 Added 3.11%	3,345 $660,000
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $23,218 - $27,114	150 Added 4.85%	3,244 $556,000
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $26,050 - $29,682	163 Added 5.56%	3,094 $563,000
Q4 2023 Jan 16, 2024	SELL	$137.6 - $154.97 $16,924 - $19,061	-123 Reduced 4.03%	2,931 $454,000
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $101,127 - $117,070	757 Added 32.96%	3,054 $455,000
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $8,348 - $10,388	63 Added 2.82%	2,297 $309,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $578 - $666	-4 Reduced 0.18%	2,234 $356,000
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $23,097 - $27,700	167 Added 8.06%	2,238 $0
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $4,965 - $5,695	37 Added 1.82%	2,071 $278,000
Q2 2022 Jul 14, 2022	SELL	$137.62 - $174.96 $9,082 - $11,547	-66 Reduced 3.14%	2,034 $312,000
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $1,847 - $2,292	-14 Reduced 0.66%	2,100 $340,000
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $859 - $1,087	8 Added 0.38%	2,114 $286,000
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $4,468 - $5,072	42 Added 2.03%	2,106 $227,000
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $5,012 - $5,518	-49 Reduced 2.32%	2,064 $223,000
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $13,924 - $18,799	-173 Reduced 7.57%	2,113 $226,000
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $12,027 - $14,116	140 Added 6.52%	2,286 $200,000
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $157,452 - $210,694	2,146 New	2,146 $211,000

Others Institutions Holding ABBV

# of Institutions

4,253

Shares Held

1.27B

Call Options Held

16.5M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $335B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Abb Vie Inc. Transaction History